Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk?

Affiliations

• ¹ School of Pharmacy, Sathyabama Institute of Science and Technology, Chennai, India.
• ² School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, India.
• ³ Department of Neurology, Massachusetts General Hospital,Harvard Medical School, Boston, Massachusetts, USA.
• ⁴ Institute of Cardiology, Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
• ⁵ Department of Neurology, Fortis Hospital, Kalyan, India.
• ⁶ Institute of Physiology and Pharmacology, Faculty of Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania.
• ⁷ NanoBioTech Laboratory, Department of Environmental Engineering, Florida Polytechnic University, Lakeland, Florida, USA.
• ⁸ National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, India.